antimicrobial stewardship

Are Community Pharmacists an Untapped Resource in Fighting Antifungal Resistance?
Are Community Pharmacists an Untapped Resource in Fighting Antifungal Resistance?Anti-fungal resistance hasn't gotten much attention — but it's a big problem.
Good News for Health-System Pharmacists
Good News for Health-System PharmacistsAn ASHP survey found that more pharmacists are being hired due to expanding roles.
Four steps managed care can take to promote antimicrobial stewardshipThe call for antimicrobial stewardship is growing. Enact these steps to prevent a return to the pre-antibiotic era.
CMS proposal to address antibiotic resistance: Key takeawaysTo participate in Medicare and Medicaid, hospital and critical access hospitals (CAHs) would need to meet new criteria.
Health-system pharmacists empower the teamHealth-system pharmacists help improve patient care, boost patient outcomes, reduce readmission rates, and lower costs — and savvy administrators know it.
Antibiotic resistance mattersAntibiotic resistances are on the rise and as such, it behooves dermatologists to use antibiotics only when necessary and in combination with topical agents wherever possible in order to help stop this alarming trend.
Antimicrobial stewardship programs aim to curb resistance problemAcute bacterial skin and skin structure infections are associated with unnecessary use of broad-spectrum antibiotics, leading to antibiotic resistance. Antimicrobial stewardship programs could be a very effective and useful approach to help stop the alarming trend of antibiotic resistance. Several strategies help optimize outcomes.
[BLOG]: Providers and payers share responsibility in making antimicrobial stewardship programs a priority
[BLOG]: Providers and payers share responsibility in making antimicrobial stewardship programs a priorityThe number of antibiotic-resistant strains continues to rise rapidly. Statistics from the Centers for Disease Control and Prevention (CDC) and the Infectious Diseases Society of America (IDSA) point to alarming trends that are exacerbated by fewer new antibiotics coming into the market and high costs.